Your browser is no longer supported. Please, upgrade your browser.
Settings
AVEO AVEO Pharmaceuticals, Inc. daily Stock Chart
AVEO [NASD]
AVEO Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.03 Insider Own0.28% Shs Outstand161.96M Perf Week33.30%
Market Cap114.42M Forward P/E- EPS next Y-0.16 Insider Trans0.00% Shs Float160.50M Perf Month-13.64%
Income-2.90M PEG- EPS next Q0.01 Inst Own30.30% Short Float10.97% Perf Quarter6.24%
Sales6.30M P/S18.16 EPS this Y92.80% Inst Trans-0.03% Short Ratio6.71 Perf Half Y-5.80%
Book/sh0.01 P/B70.65 EPS next Y-433.30% ROA-10.00% Target Price1.92 Perf Year-60.75%
Cash/sh- P/C- EPS next 5Y- ROE11.20% 52W Range0.47 - 2.25 Perf YTD-55.84%
Dividend- P/FCF- EPS past 5Y53.80% ROI313.00% 52W High-68.60% Beta0.72
Dividend %- Quick Ratio2.20 Sales past 5Y33.10% Gross Margin- 52W Low50.58% ATR0.07
Employees17 Current Ratio2.20 Sales Q/Q75.00% Oper. Margin- RSI (14)44.62 Volatility13.17% 8.89%
OptionableYes Debt/Eq12.13 EPS Q/Q-163.40% Profit Margin-46.70% Rel Volume3.58 Prev Close0.56
ShortableYes LT Debt/Eq7.00 EarningsNov 22 BMO Payout- Avg Volume2.62M Price0.71
Recom1.70 SMA20-9.63% SMA50-15.12% SMA200-7.69% Volume9,087,318 Change26.09%
Sep-11-19Upgrade H.C. Wainwright Neutral → Buy $1.75
Feb-04-19Downgrade B. Riley FBR Buy → Neutral $5 → $1
Feb-01-19Downgrade H.C. Wainwright Buy → Neutral $1
Jan-04-19Initiated Robert W. Baird Outperform
Nov-13-17Initiated B. Riley FBR, Inc. Buy $5
May-19-16Initiated Piper Jaffray Overweight $1.70
Mar-30-16Initiated FBR Capital Outperform $3
Mar-09-15Upgrade RBC Capital Mkts Underperform → Sector Perform $2 → $3
Dec-16-13Downgrade RBC Capital Mkts Sector Perform → Underperform $5 → $2
May-03-13Upgrade Stifel Sell → Hold
May-03-13Downgrade RBC Capital Mkts Outperform → Sector Perform $15 → $6
May-03-13Downgrade Canaccord Genuity Buy → Hold $2
Dec-21-12Reiterated RBC Capital Mkts Outperform $18 → $15
Nov-14-12Initiated Stifel Nicolaus Sell
May-04-12Reiterated RBC Capital Mkts Outperform $24 → $19
May-13-11Upgrade MP Advisors Underperform → Market Perform $11 → $20
Nov-30-10Initiated RBC Capital Mkts Outperform $24
Nov-29-10Initiated MP Advisors Underperform $8
Nov-13-19 01:14PM  AVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top Mark Zacks +26.09%
Nov-12-19 07:00AM  AVEO Reports Third Quarter 2019 Financial Results and Provides Business Update Business Wire +8.80%
Nov-08-19 10:08AM  Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on Rolontis Zacks
10:00AM  Global Blood's (GBT) Q3 Loss Widens, Voxelotor in Focus Zacks
Nov-07-19 11:08AM  Zoetis (ZTS) Beats on Earnings in Q3, Reports In-Line Sales Zacks
11:05AM  Horizon Therapeutics' (HZNP) Q3 Earnings Beat Estimates Zacks
07:00AM  AVEO Oncology and Biodesix Announce Initiation of the CyFi-2 Study, a Phase 2 Randomized Study of Ficlatuzumab in Combination with High-Dose Cytarabine vs. High-Dose Cytarabine Alone in Patients with Relapsed and Refractory AML Business Wire
Nov-06-19 11:00AM  Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q3 Zacks
10:34AM  Intercept (ICPT) Earnings and Sales Miss Estimates in Q3 Zacks
Nov-04-19 07:00AM  AVEO Oncology Announces Regulatory Update for Tivozanib in Renal Cell Carcinoma Business Wire -36.68%
Nov-01-19 11:30AM  AVEO Pharmaceuticals (AVEO) Earnings Expected to Grow: Should You Buy? Zacks
Oct-22-19 09:32AM  AVEO Sees Hammer Chart Pattern: Time to Buy? Zacks
Oct-17-19 08:58AM  Reata (RETA) Jumps: Stock Rises 5. 6% Zacks
Oct-16-19 09:00AM  AVEO (AVEO) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks +11.84%
Sep-30-19 07:00AM  AVEO Oncology Announces Initiation of Enrollment in Phase 1b/2 Study of FOTIVDA® (tivozanib) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma Business Wire
Sep-26-19 07:00AM  AVEO Oncology to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference Business Wire
Sep-23-19 07:00AM  AVEO Oncology and EUSA Pharma Announce Presentation of Final PFS Results from Phase 2 Portion of the TiNivo Study in Renal Cell Carcinoma Business Wire
Sep-13-19 09:36AM  Renal Cell Carcinoma Space in Focus: Some Key Developments Zacks
09:00AM  AVEO (AVEO) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Sep-11-19 11:40AM  AVEO Surges on Favorable Updated OS Results on RCC Drug Zacks +6.00%
10:49AM  Biotech Stock Roundup: AMGN's Lung Cancer Candidate, ALXN's Deal With Eidos in Focus Zacks
Sep-10-19 11:18AM  Aveo CEO says new data eases concerns about troubled kidney cancer drug American City Business Journals +30.86%
06:30AM  AVEO Oncology Announces Updated Overall Survival Hazard Ratio of 0.99 in Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma Business Wire
Sep-07-19 09:30AM  AVEO (AVEO) Up 0.2% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-19 09:13AM  Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options Zacks
Aug-09-19 11:29AM  AVEO Pharmaceuticals (AVEO) Q2 Earnings Beat, Revenues Lag Zacks
Aug-08-19 08:35AM  AVEO Pharmaceuticals (AVEO) Reports Q2 Loss, Misses Revenue Estimates Zacks
07:00AM  AVEO Reports Second Quarter 2019 Financial Results and Provides Business Update Business Wire
Jul-30-19 10:38AM  AVEO Pharmaceuticals (AVEO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Jul-08-19 05:05PM  AVEO Pharmaceuticals Down More Than 50% YTD: Here's Why Zacks
Jul-03-19 08:40AM  Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options Zacks
Jun-08-19 09:30AM  AVEO (AVEO) Down 19.9% Since Last Earnings Report: Can It Rebound? Zacks
May-29-19 07:00AM  AVEO Oncology to Present at the 2019 BIO International Convention Business Wire
May-22-19 10:26AM  Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options Zacks
May-15-19 05:00PM  AVEO Oncology Announces Presentations at the 2019 ASCO Annual Meeting Business Wire
May-11-19 02:51AM  AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark Zacks
May-10-19 03:29PM  AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark Zacks
May-09-19 08:25AM  AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:18AM  AVEO: 1Q Earnings Snapshot Associated Press
07:00AM  AVEO Reports First Quarter 2019 Financial Results and Provides Business Update Business Wire
May-07-19 10:30AM  AVEO Pharmaceuticals (AVEO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
May-01-19 05:45PM  AVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should Know Zacks
07:00AM  AVEO Oncology to Participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit Business Wire
Apr-30-19 11:39AM  AVEO Pharmaceuticals (AVEO) to Post Q1 Earnings: What's Up? Zacks
Apr-26-19 08:30AM  FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Apr-25-19 09:09PM  APRIL 26 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (AVEO) and Encourages AVEO Investors Who Suffered Losses Exceeding $100,000 to Contact the Firm GlobeNewswire
05:30PM  CLASS ACTION UPDATE for AVEO, AAPL and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:50PM  FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:57AM  CLASS ACTION UPDATE for CORT, AVEO, NIO and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:15AM  Final Deadline DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
09:00AM  FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Apr-24-19 05:45PM  AVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should Know Zacks
04:45PM  CLASS ACTION UPDATE for AVEO, KHC and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:50PM  FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, INGN and NTNX ACCESSWIRE
Apr-23-19 06:50PM  APRIL 26 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:30PM  CLASS ACTION UPDATE for AVEO, DPLO and S: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
06:28PM  AVEO FRIDAY DEADLINE ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important April 26th Deadline in Securities Class Action Lawsuit AVEO GlobeNewswire
04:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO ACCESSWIRE
04:05PM  AVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA® in Spain Business Wire
03:45PM  SHAREHOLDER ALERT: AVEO BA S: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:00PM  Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC GlobeNewswire
11:17AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO and EB ACCESSWIRE
10:14AM  Final Deadline CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Apr-19-19 06:25PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, SYNH and INGN ACCESSWIRE
05:55PM  FINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:39AM  SHAREHOLDER ALERT: CORT AVEO MBT ARA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Apr-18-19 03:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AVEO ACCESSWIRE -8.18%
02:50PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, CTL and WSR ACCESSWIRE
02:02PM  APR 26 DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. AVEO GlobeNewswire
01:40PM  IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:11AM  CLASS ACTION UPDATE for CORT, AVEO, DPLO and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:38AM  AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why Zacks
08:39AM  Will AVEO Pharmaceuticals Continue to Surge Higher? Zacks
Apr-17-19 06:45PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, AMRN and CVS ACCESSWIRE +12.24%
05:30PM  INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Apr-16-19 06:30PM  CLASS ACTION UPDATE for AVEO, CAG and WTW: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
05:45PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:34PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO GlobeNewswire
10:46AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, DPLO, UMC and NIO GlobeNewswire
10:12AM  Class Action Deadline CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Apr-15-19 06:15PM  CLASS ACTION UPDATE for AVEO, DPLO and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
05:50PM  AVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should Know Zacks
05:46PM  AVEO CLASS ACTION ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important April 26th Deadline in Securities Class Action Lawsuit; Encourages Investors With Losses in Excess of $100K to Contact the Firm AVEO GlobeNewswire
02:35PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AVEO, BRS and AMRN ACCESSWIRE
02:10PM  IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Apr-13-19 09:30AM  AVEO (AVEO) Up 71.1% Since Last Earnings Report: Can It Continue? Zacks
Apr-12-19 05:15PM  SHAREHOLDER ALERT: AVEO CAG ARA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:00PM  Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC GlobeNewswire
02:12PM  FILING DEADLINE -- Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, HCSG and NTNX ACCESSWIRE
02:00PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:12AM  Class Action Reminder CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Apr-11-19 06:54PM  CLASS ACTION UPDATE for SPB, AVEO and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
06:45PM  SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AVEO ACCESSWIRE
03:51PM  CLASS ACTION UPDATE for AVEO, INGN and BA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:45PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, STMP, CAG and SYNH GlobeNewswire
06:00AM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (AVEO) and Encourages AVEO Investors to Contact the Firm GlobeNewswire
Apr-10-19 06:10PM  CLASS ACTION UPDATE for AVEO, AMRN and SYNH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:40PM  INVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical need. It markets its lead candidate, tivozanib, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC). The company has also completed a Phase 3 TIVO-3 trial of tivozanib for the treatment of RCC; and initiated enrollment in a phase Ib/II clinical trial of tivozanib in combination with Opdivo (nivolumab), an immune checkpoint (PD-1) inhibitor, for the treatment of RCC. In addition, it is developing Ficlatuzumab, a potent hepatocyte growth factor inhibitory antibody for the treatment of squamous cell carcinoma of the head and neck, metastatic pancreatic ductal cancer, and acute myeloid leukemia; and AV-203, a potent anti-ErbB3 specific monoclonal antibody, which has completed Phase I clinical trial for treating esophageal cancer. The company's preclinical stage products include AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; and AV-353 for the treatment of pulmonary arterial hypertension. It has strategic partnerships with CANbridge Life Sciences Ltd.; EUSA Pharma (UK) Limited; Novartis International Pharmaceutical Ltd.; Biodesix, Inc.; St. Vincent's Hospital Sydney Limited; Biogen Idec; and Kyowa Hakko Kirin Co., Ltd. AVEO Pharmaceuticals, Inc. has a clinical collaboration with AstraZeneca PLC to evaluate IMFINZI (durvalumab), a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is based in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARRIS PETER J10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:19 PM
Growth Equity Opportunities Fu10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:18 PM
MAKOWER JOSHUA10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:20 PM
Makhzoumi Mohamad10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:20 PM
Florence Anthony A. Jr.10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:20 PM
BASKETT FOREST10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:19 PM
SANDELL SCOTT D10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:21 PM
MOTT DAVID M10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:21 PM
Sonsini Peter W.10% OwnerApr 08Buy1.144,347,8274,956,52325,243,865Apr 08 05:22 PM
BARRIS PETER J10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:16 PM
Growth Equity Opportunities IV10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:15 PM
Florence Anthony A. Jr.10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:17 PM
BASKETT FOREST10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:16 PM
MAKOWER JOSHUA10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:18 PM
Makhzoumi Mohamad10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:17 PM
SANDELL SCOTT D10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:18 PM
MOTT DAVID M10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:18 PM
Sonsini Peter W.10% OwnerDec 21Buy1.49300,000448,38020,896,038Dec 21 09:19 PM
MOTT DAVID M10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:18 PM
SANDELL SCOTT D10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:18 PM
Makhzoumi Mohamad10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:17 PM
MAKOWER JOSHUA10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:18 PM
BASKETT FOREST10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:16 PM
Florence Anthony A. Jr.10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:17 PM
Growth Equity Opportunities IV10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:15 PM
BARRIS PETER J10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:16 PM
Sonsini Peter W.10% OwnerDec 20Buy1.63200,000326,06020,596,038Dec 21 09:19 PM
Sonsini Peter W.10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:44 PM
MOTT DAVID M10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:43 PM
SANDELL SCOTT D10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:43 PM
Makhzoumi Mohamad10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:42 PM
MAKOWER JOSHUA10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:42 PM
Growth Equity Opportunities IV10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:40 PM
BARRIS PETER J10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:41 PM
BASKETT FOREST10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:41 PM
Florence Anthony A. Jr.10% OwnerDec 11Buy1.9861,200121,08420,396,038Dec 12 04:41 PM
Sonsini Peter W.10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:23 PM
MOTT DAVID M10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:22 PM
SANDELL SCOTT D10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:23 PM
MAKOWER JOSHUA10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:21 PM
Florence Anthony A. Jr.10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:20 PM
Makhzoumi Mohamad10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:20 PM
BARRIS PETER J10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:19 PM
BASKETT FOREST10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:19 PM
Growth Equity Opportunities IV10% OwnerDec 10Buy1.9826,00051,57620,334,838Dec 10 05:18 PM
Sonsini Peter W.10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:23 PM
MOTT DAVID M10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:22 PM
SANDELL SCOTT D10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:23 PM
MAKOWER JOSHUA10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:21 PM
Florence Anthony A. Jr.10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:20 PM
Makhzoumi Mohamad10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:20 PM
BARRIS PETER J10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:19 PM
BASKETT FOREST10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:19 PM
Growth Equity Opportunities IV10% OwnerDec 07Buy1.98117,100232,36220,308,838Dec 10 05:18 PM
Sonsini Peter W.10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:23 PM
MOTT DAVID M10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:22 PM
SANDELL SCOTT D10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:23 PM
MAKOWER JOSHUA10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:21 PM
Florence Anthony A. Jr.10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:20 PM
Makhzoumi Mohamad10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:20 PM
BARRIS PETER J10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:19 PM
BASKETT FOREST10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:19 PM
Growth Equity Opportunities IV10% OwnerDec 06Buy1.9927,30054,41420,191,738Dec 10 05:18 PM
SANDELL SCOTT D10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:13 PM
Sonsini Peter W.10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:14 PM
MAKOWER JOSHUA10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:12 PM
MOTT DAVID M10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:13 PM
Florence Anthony A. Jr.10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:11 PM
Makhzoumi Mohamad10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:12 PM
BARRIS PETER J10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:10 PM
BASKETT FOREST10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:11 PM
Growth Equity Opportunities IV10% OwnerNov 30Buy1.9871,900142,06720,164,438Nov 30 05:10 PM
SANDELL SCOTT D10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:13 PM
Sonsini Peter W.10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:14 PM
MAKOWER JOSHUA10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:12 PM
MOTT DAVID M10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:13 PM
Florence Anthony A. Jr.10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:11 PM
Makhzoumi Mohamad10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:12 PM
BARRIS PETER J10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:10 PM
BASKETT FOREST10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:11 PM
Growth Equity Opportunities IV10% OwnerNov 28Buy1.9924,50048,82420,092,538Nov 30 05:10 PM
EVNIN ANTHONY BDirectorNov 21Buy2.05109223109Nov 26 04:58 PM
BARRIS PETER J10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:44 PM
SANDELL SCOTT D10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:42 PM
MOTT DAVID M10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:42 PM
MAKOWER JOSHUA10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:43 PM
Makhzoumi Mohamad10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:43 PM
Florence Anthony A. Jr.10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:44 PM
BASKETT FOREST10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:44 PM
Growth Equity Opportunities IV10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:41 PM
Sonsini Peter W.10% OwnerNov 20Buy1.98170,000336,10720,068,038Nov 21 04:42 PM
Sonsini Peter W.10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:45 PM
MOTT DAVID M10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:44 PM
SANDELL SCOTT D10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:44 PM
Makhzoumi Mohamad10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:41 PM
MAKOWER JOSHUA10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:42 PM
Florence Anthony A. Jr.10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:41 PM
Growth Equity Opportunities IV10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:39 PM
BARRIS PETER J10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:40 PM
BASKETT FOREST10% OwnerNov 19Buy1.88510,000956,65819,898,038Nov 19 07:40 PM